SUMMARY
After cardiac surgery, it is common practice to sedate patients until normothermia is achieved, cardiovascular and respiratory stability is obtained, and weaning from mechanical ventilation can be performed. Propofol or midazolam are frequently used for this purpose.
Randomized trials comparing propofol to midazolam for sedation following cardiac surgery have observed faster recovery and weaning from mechanical ventilation when propofol sedation is used 1 . Use of propofol has been associated with relatively low heart rates, low plasma catecholamines levels 2 , and coronary artery vasodilatation which could be advantageous in postoperative cardiac surgical patients 3, 4 . These potential advantages of propofol must be balanced against propofol-induced hypotension which may jeopardize coronary perfusion pressure 1 . It has been proposed that a combination of propofol and midazolam may have advantages over either drug alone, decreasing the side-effects of propofol while preserving the potential benefits 5 . This synergism may be due to the drugs acting at different effect sites of the GABA A -receptor 6 , as there seems to be no phamacokinetic interaction 7 . Using a combined sedation strategy, Carrasco et al observed an absence of haemodynamic impairment and a reduction in dose requirement (synergistic sedation) 5 . This study aimed for a relatively long duration of sedation (more than 12 hours) and a deep level of sedation, neither of which match current usual clinical practice after cardiac surgery.
The aim of the present study was to compare the efficacy in achieving target sedation and the sideeffects (decrease of arterial pressure and prolonged weaning time) of propofol combined with a fixed, low dose of midazolam versus propofol alone for sedation of patients following coronary artery bypass grafting surgery (CABG).
METHODS

Patient selection
The study protocol was approved by the institutional ethical committee. Informed written consent was obtained the day before surgery. The inclusion and exclusion criteria of this randomized, controlled study are detailed in Table 1 . Only males were studied as there is some evidence that gender has an impact on weaning from mechanical ventilation and extubation after coronary artery bypass grafting (see discussion) [8] [9] [10] [11] .
All patients had a standard anaesthetic using fentanyl, midazolam and pancuronium. Fentanyl was administered as 100 µg boluses during the surgical procedure. Midazolam 0.1 mg/kg was administered before induction of anaesthesia, followed by a continuous infusion of 0.1 mg/kg/h until half an hour before the end of surgery or one hour before arrival in ICU. Pancuronium 0.1 mg/kg was given before induction of anesthesia, 0.05 mg/kg before the opening of the sternum and 0.05 mg/kg at the beginning of cardiopulmonary bypass.
After surgery the patients were transferred deeply sedated (Ramsay score 5 or 6 12 , see Appendix) to the surgical intensive care unit (SICU). Continuous analgesia was provided with morphine 0.02 mg/kg/h, which was initiated on arrival on the SICU. Continuous glyceryl trinitrate was administrated at a dose of 2 mg/h, which was temporarily tapered if mean arterial pressure was less than 70 mmHg. Mechanical ventilation settings (synchronized intermittent mandatory ventilation and/or pressure support) were adjusted to maintain appropriate arterial blood gas values (range of pH 7.35 to 7.45; P a O 2 /F i O 2 ratio >28 (kPa) or 210 (mmHg)).
Study design and definitions
Patients were randomized in a prospective, randomized, double-blinded fashion to receive either the combination of propofol and a low constant dose of midazolam or propofol alone. Randomization was done by computer generation and unmarked, identical vials containing either midazolam or placebo were available for the study. Neither staff monitoring the patient nor the patients were aware of group allocation. In parallel, morphine infusion was continued at 0.02 mg/kg/h for every patient. In case of insufficient analgesia, 1g active substance of paracetamol could be added intravenously, and could be repeated every six hours. Insufficient analgesia was defined as a nod of the patient's head when asked if they were in pain. In the absence of a nod, a new tachycardia (heart rate >100 beats/min), new arterial hypertension (increase of MAP of >20%) or tears after exclusion of other causes were considered as insufficient analgesia. Sedation was not administered after ICU admission until a Ramsay score of 4 had been reached (Figure 1 ). This meant that all subjects had recovered from anaesthesia to a defined point which was the starting point for the study. The patient then received, in a blinded fashion, either a continuous infusion of midazolam 1mg/h (Dormicum ® , Roche Pharma AG, Reinach, Switzerland) (group midazolam+intention-to-treat with propofol) or placebo at the same rate (group placebo+intention-to-treat with propofol). The Ramsay score was assessed every half hour during the conscious sedation. In both groups, if the sedation level was not sufficient, a propofol infusion (Zeneca Pharma AG, Luzern, Switzerland) was commenced with stepwise increases of 0.25 mg/kg/h every five minutes until the target Ramsay score was achieved. Patients receiving propofol were assigned to the subgroups mida- Preoperative exclusion criteria * age over 80 or under 16 years * female gender * total serum bilirubin >50 micromol/l, * serum creatinine >150 mmol/l, * vital capacity <40 ml/kg * forced expiratory volume in the first second <50% of the predicted value * central nervous system (CNS) disease * alcoholism * dependency upon chronic CNS acting medications Exclusion criteria during and after surgery * perioperative myocardial infarction (new ST changes and MB isoenzyme fraction of creatine phosphokinase (10% of total creatine phosphokinase six hours or later following CABG) * new central nervous system disease [stroke (new hemiparesis, new hemiplegia, and a CT scan with corresponding cerebral lesions)] * onset of withdrawal syndrome (altered attention, hallucinations, or agitation, without new alterations on CT scan and a history of withdrawal of a medication or alcohol) * delirium (altered attention, hallucinations or agitation without new alterations on CT scan) zolam+propofol and placebo+propofol. Efficacy of sedation per time period (half hour) was defined as the per cent of patients with adequate sedation (Ramsay score between 3 and 5) per time period in each group. The Ramsay scale was chosen for this study because it is used on a regular basis in our unit. The study observation period began following admission to the SICU and ended after tracheal extubation ( Figure 1 ). Before ending the sedation and beginning the extubation process, the following predefined criteria were required: 1. Mean arterial pressure between 60 and 100 mmHg, no ventricular arrhythmia, and adequate peripheral circulation by clinical examination, i.e. warm feet and hands. 2. Inspiratory fraction of oxygen (F i O 2 ) <0.5, an arterial oxygenation (P a O 2 ) >9 kPa (68 mmHg), at a positive end-expiratory pressure (PEEP) <7 cmH 2 O. 3. Chest tubes draining <150 ml/h. 4. Temperature >37°C. 5. Ramsay score <5.
During the first two periods of the protocol, the nurse in charge of the study patient noted the sedation level, heart rate, mean arterial pressure, rectal temperature every 30 minutes and adjusted the mechanical ventilation to achieve an arterial carbon dioxide partial pressure (P a CO 2 ) of 4.5 to 5.5 kPa (34 to 41 mmHg) using synchronized intermittent mandatory ventilation or pressure support. The predefined criteria for extubation were unassisted spontaneous breathing with a continuous positive airway pressure (CPAP) <7 cmH 2 O for at least 15 minutes at an F i O 2 <0.5 resulting in a P a O 2 >9 kPa (68 mmHg) and a P a CO 2 <6 kPa (45 mmHg); pH had to be >7.29 and <7.51.
Statistical analysis
Data obtained for each group during the observation period was compared. Patients who had not achieved a Ramsay score of 4 before initiation of the extubation process (and thus did not receive propofol) were included in the intention-to-treat analysis, but excluded for the final analysis. The average efficacy of sedation was calculated over seven hours of the conscious sedation time period because beyond this time the group sizes were too small (less than one third of patients). Continuous data and qualitative data were analyzed with Mann-Whitney U tests, except the haemodynamic data which were analysed with the unpaired t-test with Welch correction. Non-parametric analysis was chosen, because normal distribution cannot be assumed with the size of the groups. Proportions were compared with the Fisher's Exact Test. The cumulative reduction of the numbers of patients in the two groups (related to the differential tracheal extubation times) during the weaning period were analysed using the Kaplan- Meier estimation and compared with the log rank test (Mantel-Cox). Data are presented as mean (±SD). A P<0.05 was considered statistically significant. The number of patients required in each group was calculated on the assumption that adding low dose midazolam to propofol infusion could increase weaning time for the same level of sedation. Power test (α= 5%; β=80%) based on the weaning time data of Roekerts et al who demonstrated an average difference of 36%, required at least 15 patients per group 13 . Taking into account that after cardiac surgery approximately 20% of patients do not need any supplementary sedation at our institution, and that our pharmacological study design did not correspond exactly to that used by Roekaerts et al, we decided to include >25 patients in each group.
RESULTS
Data of all patients (intention-to-treat with propofol)
Sixty patients were randomized. Seven patients were excluded after enrollment for the following reasons: acute myocardial infarction (n=1), stroke (n=1), prolonged anaesthesia (>8 hours, n=1), emergency re-operation for haemostasis (n=2) and protocol violation (n=2). No patient died during the course of the study. Demographic and surgical data for these 53 patients were similar for the groups midazolam+intention-to-treat with propofol and placebo+intention-to-treat with propofol (Table 2) . Fluid balance during the observation period (1916± 1808 ml vs 2035±1594 ml), haemodynamic variables (heart rate at the start of conscious sedation 96±16 vs 93±14, heart rate at the end of conscious sedation 88±10 vs 88±12; mean arterial pressure at the start of conscious sedation 88±10 mmHg vs 88±12 mmHg and mean arterial at the end of conscious sedation 75±13 mmHg vs 75±10 mmHg) and drug administration (dose of glyceryl trinitrate: 0.31±15 µg/kg/min vs 0.32±0.16 µg/kg/min; number of patients treated with catecholamines: 9 vs 8; number of patients treated with antihypertensive agents: 2 vs 4) were comparable between the groups.
The median of the Ramsay score was always 4 during the conscious sedation period in both groups, except for one time period, at five hours after initiation of the conscious sedation in the group placebo+intention-to-treat with propofol. The average efficacy of sedation during the conscious sedation period was 91% in group midazolam+ intention-to-treat with propofol, and 79% in group placebo+intention-to-treat with propofol (P=0.0005). The duration of the different time periods were similar except for a longer period for weaning from mechanical ventilation in the group midazolam+intention-to-treat with propofol compared with the group placebo+intention-to-treat with propofol (432±218 min vs 319±223 min, P=0.04).
Data of patients receiving propofol
Eighteen (group midazolam+propofol) of the 27 patients (group midazolam+intention-to-treat with propofol) needed propofol to maintain the target sedation of grade 4 on the Ramsay scale (66.6%). Seventeen (group placebo+propofol) of the 26 patients (group placebo+intention-to-treat with propofol) needed propofol (65.4%). Demographic and surgical data for the 35 patients requiring propofol were similar for the two groups (midazolam+propofol and placebo+propofol) ( Table 3) . Duration of the different time periods, fluid balance, haemodynamic variables and drug administration were comparable between these two groups (Table 4) .
A decrease in mean arterial pressure from 94± 19 mmHg at the beginning of the conscious sedation period to 65±10 mmHg 6 hours later (nadir) was noted in the group midazolam+propofol and from 95±17 mmHg to 68±8 mmHg in the group placebo+propofol (P<0.001 for both groups); there was no statistically significant difference between the groups for mean arterial pressure; 3/18 patients in the group midazolam+propofol required extra fluid treatment for hypotension compared to 0/17 patients in the group placebo+propofol group (P ns). Tachycardia (>100 beats/min) was maximal at two hours of conscious sedation, and was seen in 7/18 patients in the group midazolam+propofol compared to 3/17 patients in the other group (P ns). The median of the Ramsay score was always 4 during the whole conscious sedation period in both groups receiving propofol. The average efficacy of sedation during the conscious sedation period was 90% in group midazolam+propofol, and 78% in group placebo+propofol (P=0.0063). A longer period for weaning from mechanical ventilation was observed in the group midazolam+propofol compared with the group placebo+propofol (P=0.03) ( Table 3 ). Three hours after the discontinuation of sedation, three out of 18 patients (17%) were extubated in the group midazolam+propofol, compared with six out of 17 patients (35%) in the group placebo+propofol. Figure 2 shows percentage of extubated patients in both groups. No patient had to be reintubated.
DISCUSSION
The main results of this randomized, doubleblinded, placebo-controlled trial in males following CABG comparing propofol and midazolam with propofol alone were a statistically significant difference in sedation efficacy, and a clinically relevant difference in weaning time. The group coadministered midazolam and propofol had higher percentages of reached target sedation and longer times to extubation after sedation discontinuation. The decrease in arterial blood pressure was similar in both groups. Administration of midazolam did not allow a reduction in the dose of propofol. Under the trial conditions (fentanyl and midazolam based anaesthesia, a goal of conscious sedation postoperatively, routine sedation evaluation score, and continuous low dose morphine) one third of the patients did not need supplementary sedation in the postoperative period.
The target sedation was more often reached in the propofol and midazolam group. The clinical relevance of this difference remains to be defined, but inadequate sedation and agitation may increase the incidence of unexpected extubation and can be fatal 14 . The target sedation results obtained correspond to the results observed in a systematic review on sedation with propofol or midazolam 1 and both types of sedation can be regarded as effective for this end-point.
There is good evidence that sedation has a major impact on weaning from mechanical ventilation and that sedation guidelines may decrease weaning time and ICU stay 15, 16 . We observed that weaning time is statistically significantly influenced by coadministration of hypnotic drugs. Omitting midazolam reduced the weaning time by 37% on average. A similar result with an average reduction of weaning time of 25% was described in a randomized controlled trial in the same clinical setting 5 . A randomized controlled trial evaluating sedation for interventional endoscopic procedures with either propofol alone or propofol and midazolam observed an average reduction of recovery time of 24%. Faster recovery and weaning may have advantages such as early neurological assessment in this population at risk of stroke 17 and may allow a reduction in the nurse-to-patient ratio 18 .
It has been suggested that midazolam administration would reduce propofol requirements 19 . Carrasco et al 5 , in contrast to our results, confirmed this hypothesis in patients after cardiac surgery. These conflicting results may be due to the shorter duration of sedation in our study (average 6.7 hours vs 14.7 hours in the Carrasco study), the different doses of midazolam (1.0 mg/h vs 2.0 mg/h in the Carrasco study), and the fixed midazolam dose in our study compared with a variable dose in the Carrasco study. The mean maintenance dose of propofol in the Carrasco study was more than double ours. It is possible that the dose of midazolam in our study may have been too low to reduce propofol administration.
Our study only included male subjects. There is some evidence that gender has an impact on weaning from mechanical ventilation and extubation after coronary artery bypass grafting [8] [9] [10] [11] . Duration of perioperative ventilation, i.e. intubation in the operating room until extubation in the ICU, was significantly longer for women compared with men (mean 77 hours versus mean 49 hours) 8 , and early extubation was less often possible in women than in men (64% versus 74%) 9 . Based on this literature, we excluded women in our study.
One third of our patients needed no further sedation. This is most likely due to the high doses of hypnotics and analgesics used during anesthesia, routine postoperative morphine infusion and the fact that the individual need for sedation may vary considerably. This observation emphasizes the importance of regular evaluation of sedation level combined with sedation management guidelines (allowing unnecessary sedation to be avoided), and the use of an intention-to-treat study design in clinical trials in sedation research.
In conclusion, co-administration of propofol and low dose of midazolam prolonged the duration from the end of sedation to extubation in patients following coronary artery bypass grafting surgery, and only marginally improved the percentage of appropriately sedated patients compared with propofol alone. All patients received high-dose midazolam/fentanyl anaesthesia for their cardiac surgery and postoperative morphine infusion. One third of all patients did not need further hypnotics for sedation. Our results suggest that propofol alone has advantages over propofol midazolam co-administration should further postoperative sedation be required.
